Biotech · Private company
Athenex, Inc.
Track this companyFree. Adds Athenex, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials150 recruiting or active
Pipeline programs13From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline13
- KX2-391Phase 2 · Bone-Metastatic, Castration-Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- OraxolPhase 2 · Angiosarcoma of SkinClinicalTrials.gov · fetched Nov 12, 2026
- KUR-502Phase 1 · NHL, Relapsed, AdultClinicalTrials.gov · fetched Nov 12, 2026
- KX2-361Phase 1 · Advance MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- KX2-391 Ointment 1%Phase 1 · Actinic KeratosesClinicalTrials.gov · fetched Nov 12, 2026
- OradoxelPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- OratecanPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- OratopoPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- OraxolPhase 1 · Gastric CancerClinicalTrials.gov · fetched Nov 12, 2026
- OraxolPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- PT01 (Pegtomarginase)Phase 1 · Advanced Solid MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- RamucirumabPhase 1 · Gastric CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials15
- Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell MalignanciesPHASE1 · UNKNOWN · started Oct 1, 2022ClinicalTrials.gov NCT05487651 · fetched Nov 12, 2026
- A Phase I Open-label Study for Subjects With Advanced MalignanciesPHASE1 · UNKNOWN · started Apr 21, 2021ClinicalTrials.gov NCT04136834 · fetched Nov 12, 2026
- A Study of Oraxol in Subjects With Cutaneous AngiosarcomaPHASE2 · COMPLETED · started Dec 21, 2018ClinicalTrials.gov NCT03544567 · fetched Nov 12, 2026
- Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid TumorsPHASE1 · TERMINATED · started Oct 25, 2018ClinicalTrials.gov NCT03588039 · fetched Nov 12, 2026
- Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic KeratosisPHASE1 · COMPLETED · started Sep 7, 2018ClinicalTrials.gov NCT03575780 · fetched Nov 12, 2026
- Evaluate Oral Topotecan With HM30181A Monotherapy in Patients With Advanced MalignanciesPHASE1 · COMPLETED · started Jul 19, 2018ClinicalTrials.gov NCT03987685 · fetched Nov 12, 2026
- A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or ScalpPHASE3 · COMPLETED · started Sep 18, 2017ClinicalTrials.gov NCT03285477 · fetched Nov 12, 2026
- A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)PHASE3 · COMPLETED · started Sep 15, 2017ClinicalTrials.gov NCT03285490 · fetched Nov 12, 2026
- A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. MalignanciesPHASE1 · UNKNOWN · started Apr 20, 2017ClinicalTrials.gov NCT02963168 · fetched Nov 12, 2026
- Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal CancersPHASE1 · UNKNOWN · started Dec 8, 2016ClinicalTrials.gov NCT02970539 · fetched Nov 12, 2026
- Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or ScalpPHASE2 · COMPLETED · started Apr 11, 2016ClinicalTrials.gov NCT02838628 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. MalignanciesPHASE1 · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT02730481 · fetched Nov 12, 2026
- Safety, Tolerability & PK of KX2-361 in Subjects w Adv. Malignancies Refractory to Conventional TherapiesPHASE1 · COMPLETED · started Dec 1, 2014ClinicalTrials.gov NCT02326441 · fetched Nov 12, 2026
- A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects With Advanced MalignanciesPHASE1 · COMPLETED · started Sep 5, 2014ClinicalTrials.gov NCT02250157 · fetched Nov 12, 2026
- Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate CancerPHASE2 · COMPLETED · started Feb 1, 2010ClinicalTrials.gov NCT01074138 · fetched Nov 12, 2026